CTIS2024-512578-83-00招募中1 期
GSBR-1290-07
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 8
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Study to evaluate the addition of an experimental drug, CC-90010, to the usual treatment of brain cancer after surgerySubjects with newly diagnosed WHO Grade IV glioblastoma (ndGBM) who have undergone complete or partial tumor resectionMedDRA version: 20.0Level: PTClassification code: 10018336Term: Glioblastoma Class: 100000004864CTIS2024-511171-15-00Celgene Corp.216
进行中（未招募）
1 期
A Phase 1b, Randomized, Open-Label Trial to Evaluate Safety, Engraftment, and Initial Signs of Clinical Activity of MB097 in Combination with Pembrolizumab in Melanoma Patients with Primary Resistance to an Anti-PD-1-Containing Immunotherapy (MELODY-1)MedDRA version: 21.1Level: PTClassification code: 10025650Term: Malignant melanoma Class: 100000004864Advanced MelanomaCTIS2023-507377-17-00Microbiotica Limited40
招募中
1 期
A Study of SGN-B7H4V in Advanced Solid Tumorson-small cell lung cancer (squamous cell carcinoma [SqCC]), HER2-negative, HR-positive breast cancer, Adenoid cystic carcinoma (ACC) of the head and neck, Triple-negative breast cancer, High-grade serous epithelial ovarian cancer, Fallopian tube cancer, Endometrial carcinoma, Primary peritoneal cancer, Cholangiocarcinoma, Gallbladder carcinomaMedDRA version: 20.0Level: PTClassification code: 10075566Term: Triple negative breast cancer Class: 100000004864MedDRA version: 24.0Level: PTClassification code: 10085481Term: Hormone receptor positive HER2 negative breast cancer Class: 100000004864MedDRA version: 21.0Level: PTClassification code: 10014733Term: Endometrial cancer Class: 100000004864MedDRA version: 21.1Level: PTClassification code: 10061873Term: Non-small cell lung cancer Class: 100000004864MedDRA version: 20.0Level: PTClassification code: 10008593Term: Cholangiocarcinoma Class: 100000004864MedDRA version: 20.0Level: PTClassification code: 10017614Term: Gallbladder cancer Class: 100000004864MedDRA version: 20.0Level: PTClassification code: 10061328Term: Ovarian epithelial cancer Class: 100000004864MedDRA version: 21.0Level: PTClassification code: 10053231Term: Adenoid cystic carcinoma Class: 100000004864MedDRA version: 20.0Level: PTClassification code: 10016180Term: Fallopian tube cancer Class: 100000004864MedDRA version: 21.0Level: PTClassification code: 10061269Term: Malignant peritoneal neoplasm Class: 100000004864CTIS2023-503389-22-00Seagen Inc.400
招募中
1 期
Study of safety, tolerability and efficacy of DFV890 in participants with myeloid diseasesCTIS2022-501406-36-00ovartis Pharma AG80
进行中（未招募）
1 期
Dendritic cell therapy combined with surgery in mesothelioma (ENSURE)Adult patients diagnosed with resectable epithelioid MPM, following first-line chemotherapy.CTIS2024-514054-70-00Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)14